YALE FIKRIG/FLAVELL FLAGELLIN METHOD
Mort Zuckerman
kshe...@calea.org, fit...@gmail.com, patrick.f...@usdoj.gov,
model...@sbcglobal.net, jdr...@nejm.org, let...@courant.com,
Jgerb...@cdc.gov, len...@courant.com, michae...@po.state.ct.us,
con...@po.state.ct.us, executiv...@nytimes.com, managing-
edi...@nytimes.com, news...@nytimes.com, the-...@nytimes.com,
biz...@nytimes.com, for...@nytimes.com, me...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, ubi...@courant.com, ma...@concentric.net,
camp...@courant.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@po.state.ct.us, kur...@washpost.com,
georg...@washpost.com, hor...@courant.com,
commissi...@po.state.ct.us, cohen...@aol.com,
FalN...@aol.com, brans...@comcast.net, vts...@comcast.net,
o...@po.state.ct.us, da...@davila-dilzer.com,
scott....@po.state.ct.us, govern...@po.state.ct.us,
attorney...@po.state.ct.us, randall...@usdoj.gov
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, hor...@courant.com,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, thomas...@usdoj.gov, amcg...@rms-law.com,
rjmu...@aol.com, paulcrai...@yahoo.com,
sidney_b...@yahoo.com, criminal...@usdoj.gov,
karla.d...@usdoj.gov, christophe...@usdoj.gov
Subject: YALE FIKRIG/FLAVELL FLAGELLIN METHOD
Date: Jun 14, 2008 12:14 PM
They clearly state that this method is accurate and specific:
"An unexpected advantage of the flagellin polypeptides of this
invention is
their high sensitivity. They are capable of detecting B. burgdorferi-
specific antibodies
in ***the vast majority*** of confirmed seropositive samples tested.
Another advantage
of the flagellin polypeptides of this invention is their high level of
***specificity***
--a minimal number of false positives due to a very low level of cross-
reactivity
with antibodies directed against treponemes and other bacteria."
Here is the original 1991 Fikrig/Flavell report that goes with the
5,618,533 patent:
http://iai.asm.org/cgi/reprint/59/10/3531?view=long&pmid=1894359
Look at the graphic on page 3533.
They are clearly selecting out a section of flagellar DNA that
does not cross react with antibodies against flagella from other
organisms, which means it is a SPECIFIC test for Borrelia
burgdorferi flagellin antibodies... which almost all Lyme
victims have.
So, why wasn't this test used to assess the outcome of Yale's
LYMErix vaccine?
Even Alan Barbour proposed such a concept when he patented the
flagellar-less
spirochete:
"In addition to the reduced potential for elicitation of undesirable
autoimmune
responses and the ability to be administered as live attenuated
vaccines, the novel
vaccines possess the additional advantage of facilitating diagnosis of
Borreliosis
in individuals, mammals, and birds who have been administered the
vaccine. As those
of skill in the art will recognize, few if any vaccines are one
hundred percent
efficacious and vaccine failures do occur. Furthermore, when the
disease vaccinated
against is a disease which, like Lyme disease, elicits symptoms that
can be attributed
to a number of other pathologic conditions, specific immunodiagnostic
assays may
be complicated by antibodies elicited against the vaccine. ***In
contrast, when
the flagella-less microorganisms of the present invention are used for
immunization,
one can simply assay an individual exhibiting symptoms characteristic
of a selected
borrelial pathogenesis, such as Lyme disease, for antibodies to the
flagellar-antigen.
In such individuals, the absence of such antibodies will usually weigh
against a
diagnosis of Borreliosis, and their presence will be suggestive of a
vaccine failure.***"
He is saying to vaccinate with a flagellar-less spirochete, but then
test for vaccine
failure using a Borreliosis-specific recombinant flagellar antigen
because we don't
want
to vaccinate with flagellin, since that causes an autoimmune
neurologic disease.
LOL.
But, according to the Yale Lyme Crooks, "No one can HAVE an
antibody to flagellin (band 41) and be sick," just like, at the
present time, the crooks say, "No one can have band 31 (OspA) and
be diagnosed with "Lyme Disease," despite that being the LYMErix
vaccine.
LOL.
Very funny. They went with an OspA vaccine because they
thought band 41 would be a bad idea to give someone because it
causes neurologic disease, but about people who already have
band 41 from Lyme infection, these crooks say, "YOU'RE *INSANE*
TO BE SAYING YOU HAVE A NEUROLOGIC DISEASE!!"
Yale's Eugene Shapiro even perjured hiimself and said he
"never saw a case of neurologic Lyme Disease in children..."
completely confident that no one understands that "Lyme
Disease" is now the knee-only disease caused by OspA (caused
by LYMErix, which was why SmithKline was sued by Steve Sheller)
thanks to the FRAUD in testing committed by Allen Steere
in Europe:
http://www.actionlyme.org/CRYMEDISEASE_CHP3_B.htm
It's not actually funny, because by not using the Yale
flagellin method, they are allowing people to progress
to late neurologic disease and death:
http://www.actionlyme.org/ALSLYME47.htm
http://www.actionlyme.org/BRAIN_PERMANENT.htm
There is no disputing the claim that these Yale creeps
are murderers, since this is clearly their own data
and it shows they know what the rules are for
developing an accurate test for all cases of Lyme,
especially the earliest cases, since the first
antibody to show up is band 41 or flagellin.
These assholes know I know what they did in their
labs which is why they invented for me that I
was a "dangerously intelligent terrorist chemist."
Kathleen M. Dickson